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Résumé en
anglais
In this study, a new active targeting strategy to favour ferrociphenol (FcdiOH)
internalisation into brain tumour cells was developed by the use of lipid
nanocapsules (LNCs) coated with a cell-internalising peptide (NFL-TBS peptide)
that interacts with tubulin-binding sites. In comparison, OX26 murine monoclonal
antibodies (OX26-MAb) targeting transferrin receptors were also inserted onto LNC
surface. The incorporation of OX26 or peptide did not influence the in vitro
antiproliferative effect of FcdiOH-LNCs on the 9L cells since their IC50 values were
found in the same range. In vivo, intracerebral administration of OX26-FcdiOH-
LNCs or peptide-FcdiOH-LNCs by convection enhanced delivery did not enhance
the animal median survival time in comparison with untreated rats (25days).
Interestingly, intra-carotid treatment with peptide-FcdiOH-LNCs led to an
ameliorated survival time of treated rats with the presence of animals surviving
until days 35, 40 and 44. Such results were not obtained with OX26-MAbs,
demonstrating the benefit of NFL-TBS peptide as an active ligand for peripheral
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